CLDN1 and type 2 diabetes mellitus: Consistent with these findings, our results demonstrated that MEP treatment restored intestinal permeability by enhancing tight junctions (ZO-1, occludin, and claudin-1), regulating MUC2 protein expression, and reducing endotoxemia through lowering LPS levels in the T2DM mice.